Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT ID: NCT05514951
Last Updated: 2025-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
888 participants
INTERVENTIONAL
2022-11-15
2022-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Apart from anemia, iron deficiency is common and constitutes a factor of poor prognosis in diseases chronic, all pathologies very frequently found in the elderly. It is the origin of the deterioration in the general condition of patients, their re-hospitalization or even the progression of their pathology.
In this context where elderly patients also present a certain number of comorbidities including the pathologies mentioned previously, it is important to better diagnose the deficiency martial in the elderly patient.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Out Come Study To Define Laboratory Parameters That Are Best Suited to Diagnose Functional Iron Deficiency
NCT00495781
Clinical Signs and Symptoms of Anemia in Patients Over 75 Years
NCT02662699
Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency
NCT04139265
Anemia in the Elderly
NCT00640172
Iron Deficiency Anemia in Childern With Liver Cirrhosis
NCT03482076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Anemia is the most common haematological pathology encountered in geriatric practice. Its prevalence, in population generally ambulatory, is between 10 and 15% after the age of 65 and is greater than 20% beyond the age of 85.
Anemia should never be neglected in an elderly subject because it is associated with an increase in mortality, but also with a increased morbidity in terms of complications heart disease, cognitive decline, frailty, hospitalizations, and impairment of quality of life. About a third of anemias elderly person is attributable to a deficiency in vitamin B9 or B12 or an iron deficiency.
Apart from anemia, iron deficiency is common and constitutes a factor of poor prognosis in diseases chronic such as heart failure, kidney failure chronic or cancer, all pathologies very frequently found in the elderly. It is the origin of the deterioration in the general condition of patients, their re-hospitalization or even the progression of their pathology.
In this context where elderly patients also present a certain number of comorbidities including the pathologies mentioned previously, it is important to better diagnose the deficiency martial in the elderly patient.
This diagnosis is all the more important because, depending on the chronic pathology, data from the literature have shown that correcting the iron deficiency brings benefits to the patient by reducing the risk of recurrence of anemia, the prescription of erythropoietin and the use of transfusion for patients in oncology, gastroenterology and nephrology
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood sampling
Blood sampling
Blood sampling
Blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling
Blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated patient or beneficiary of a social healthcare system
* Patient having given written consent
Exclusion Criteria
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vifor Pharma
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Angers
Angers, , France
CH de Bayonne
Bayonne, , France
Ch De Calais
Calais, , France
CH Chambéry
Chambéry, , France
CHSF
Corbeil-Essonnes, , France
Ch de Dunkerque
Dunkirk, , France
Hôpital Gériatrique Les Bateliers Chu Lille
Lille, , France
Chu De Nantes, Hôpital Bellier
Nantes, , France
CHU de NICE-hopital CIMIEZ
Nice, , France
Hopital Saint Antoine
Paris, , France
CH de Pau
Pau, , France
CHU de Poitiers
Poitiers, , France
HUS - Hôpitaux Universitaires de Starsbourg
Strasbourg, , France
Hôpital Bretonneau
Tours, , France
Chu Nancy
Vandœuvre-lès-Nancy, , France
HCL
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fougere B, Puisieux F, Chevalet P, Annweiler C, Michel E, Joly L, Blanc F, Azouzi AE, Desre-Follet V, Cacoub P; CARENFER PA study group*. Prevalence of iron deficiency in patients admitted to a geriatric unit: a multicenter cross-sectional study. BMC Geriatr. 2024 Jan 30;24(1):112. doi: 10.1186/s12877-024-04719-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00787-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.